Franklin Resources, Inc. 13D and 13G filings for Benitec Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-29 11:34 am Sale | 2025-12-31 | 13G | BENITEC BIOPHARMA INC BNTC | FRANKLIN RESOURCES INC BEN | 3,751,709 10.600% | -392,328 (-9.47%) | Filing |
| 2025-11-04 11:49 am Sale | 2025-09-30 | 13G | BENITEC BIOPHARMA INC BNTC | FRANKLIN RESOURCES INC BEN | 4,144,037 14.900% | -271,093 (-6.14%) | Filing |
| 2025-05-09 1:06 pm Sale | 2025-03-31 | 13G | BENITEC BIOPHARMA INC BNTC | FRANKLIN RESOURCES INC BEN | 4,415,130 16.300% | -78,561 (-1.75%) | Filing |
| 2025-01-27 12:51 pm Purchase | 2024-12-31 | 13G | BENITEC BIOPHARMA INC BNTC | FRANKLIN RESOURCES INC BEN | 4,493,691 18.100% | 239 (+0.01%) | Filing |
| 2024-11-07 12:30 pm Purchase | 2024-09-30 | 13G | BENITEC BIOPHARMA INC BNTC | FRANKLIN RESOURCES INC BEN | 4,493,452 15.100% | 3,905,215 (+663.88%) | Filing |
| 2023-12-11 12:41 pm Purchase | 2023-11-30 | 13G | BENITEC BIOPHARMA INC BNTC | FRANKLIN RESOURCES INC BEN | 588,237 22.900% | 2 (+0.00%) | Filing |
| 2023-09-11 11:27 am Unchanged | 2023-08-31 | 13G | BENITEC BIOPHARMA INC BNTC | FRANKLIN RESOURCES INC BEN | 588,235 28.500% | 0 (Unchanged) | Filing |